content

Mylan to invest $1 Billion in India on capex in 6 years

World Pharma Today / News / India - Mylan, a global generic and specialty Pharmaceuticals Company registered in the Netherlands has confirmed that in...

Acceleron Pharma discontinues development of muscular dystrophy drug

The clinical-stage biopharmaceutical company Acceleron Pharma Inc. has announced the discontinuation of the development of drug for facioscapulohumeral muscular dystrophy (FSHD), ACE-083. Further clinical...

The Ever Growing Pharma Software Market in India

Globally, the acceptance of software in the pharma sector is much more as compared to India but many front line manufacturers have understood the...

Signant Health Proudly Sponsors “DISORDER: The Rare Disease Film Festival” to Raise Awareness and Hope for Millions of Families Worldwide

There are 7,000 recognized rare disease conditions that affect between 25 and 30 million people in the United States alone, and the vast majority...

CPhI Pharmaceutical Machinery Report: โ€˜critical time to invest in machinery with changing drugs pipelineโ€™

Ahead of P-MEC 2019, the only dedicated pharmaceutical machinery event in Europe this year โ€“ co-located with CPhI Worldwide in Frankfurt, 5-7 November โ€“...

Hospital Angelina Caron joins the Patient Network Explorer platform, expanding Clinerion’s global hospital network in Brazil

Hospital Angelina Caron, of Campina Grande do Sul, Paranรก, is the latest Brazilian hospital to join Clinerionโ€™s network of partner hospitals on its Patient...

DuPont to Enter Strategic Collaboration on Probiotics with BY-HEALTH

Satisfying consumersโ€™ growing demands for probiotics for everyday life DuPont Nutrition & Biosciences today announced its intent to enter into a strategic collaboration with BY-HEALTH,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read